Cancer Cachexia Market - Global Industry Growth and Forecast 2016 - 2024
In cachexia the CD4 count drops below CD8 count having a major impact on the loss of appetite until the patient develops anorexia. The astonishing part is that the body still needs nourishment to perform day to day activity and withstand the chemotherapy treatment. To fulfill the unmet energy requirement it begins the breakdown of fat stores alternatively coined as glycogenesis. The metabolic activity of tumor or cancer cells is completely different from normal cell. Normal body cells metabolizes aerobically as compared to cancer cells which metabolizes anaerobically through a process of fermentation. In fermentation process the amount of sugar required is much higher than normal cell and hence leads to death of patient out of starvation or inability to feed tumor.
Obtain Report Details @ http://www.transparencymarketresearch.com/cancer-cachexia-market.html
Cancer Cachexia Market: Drivers and Opportunities
Overall cachexia is characterized into three prominent stages namely pre-cachexia, cachexia and refractory cachexia. In pre-cachexia stage patients lose muscles mass despite the overall weight being unaffected. In cachexia the patient undergoes prominent weight loss and muscles depletion yet the weight loss can be controlled with the help of health supplements. In refractory cachexia, the reversal of weight loss is negligible even with the diet supplements however the symptoms of cachexia such as nausea or tiredness can be alleviated.
Currently there is no therapeutic agent approved for cachexia treatment, although two classes of drugs, progestins and steroids are commonly used off-label. Looking at the exponential rise in the global cancer patients and continuous demand for nutrient supplements for combating cancer and other immunological disorders many pharma giants are now in a process to develop novel vaccines or drugs to fulfill the unmet global demand which act as a prominent driver for the global cancer cachexia market. Some of the pipelined and available drugs in the cancer cachexia market include enobosarm, anamorelin hydrochloride, bimagrumab, dronabinol among others.
Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15482
Cancer Cachexia Market: Region-wise Outlook
Geographically, though the demand for such cancer drugs and supplements are in great demand yet with respect to revenues the cancer cachexia market is currently dominated by developed economic countries such as the United States and Europe. Owing to rise in demand for novel and low cost medicines and increase in government interventions and university based research studies has led to significant growth and awareness among about such therapeutics among physicians as well as cancer patients.
Asia-Pacific and Rest of the World cancer cachexia market is expected to be the fastest growing cancer cachexia market due to past improvements in healthcare infrastructure and rise in cancer care centers. Looking at the untapped potential of the Asian and Middle East market many key players in the cancer cachexia market have focused their sales and manufacturing services towards these emerging and growing countries. Lack of approved therapeutics in the cancer cachexia market is major restraints to the growth and acceptance of drugs.
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700, Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
Visit Blog: http://marketresearchreports2017.blogspot.in
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Cachexia Market - Global Industry Growth and Forecast 2016 - 2024 here
News-ID: 706127 • Views: 206
More Releases from Transparency Market Research - Pharmaceutical
Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market: Introduction Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027. Overview Radiofrequency ablation is a minimally invasive surgical
More Releases for Cachexia
Global Cancer Cachexia Market to be Driven by the Rising Number of Cache …
The new report by Expert Market Research titled, 'Global Cancer Cachexia Market Report and Forecast 2022-2027', gives an in-depth analysis of the global cancer cachexia market, assessing the market based on its segments like therapeutics, mechanisms of action, distribution channels, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on
Cachexia Market 2020 Research by Expert
Cachexia - Pipeline Insight, 2019 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Cachexia Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought
Cancer Cachexia Market for Surgical Robotics (2020-2027)
The global cancer cachexia market is anticipated to gain traction from the rising shift of the healthcare providers towards combination therapies. Such therapies are aiding in improving the lean body mass (LBM) of patients. This information is given by Fortune Business Insights™ in a recently published report, titled, “Cancer Cachexia Market Size, Share & Covid-19 Impact Analysis, By Product (Progestogens, Corticosteroids, Combination Therapies, and Others), By Distributional Channel (Hospital Pharmacy,
Cancer Cachexia Market 2018 - Evolving Approach to Management of Cancer Cachexia
In 2018, the market size of Cancer Cachexia is million US$ and it will reach million US in 2025, growing at a CAGR of from 2018; while in China, the market size is valued at xx million US$ and will increase to xx million US in 2025, with a CAGR of xx% during forecast period. In this report, 2017 has been considered as the base year and 2018 to 2025 as
Learn Details of the Cachexia Treatment Market Report
Cachexia is a condition associated with loss of weight and muscle mass in response to a chronic disease. The condition is a symptom of chronic disease such as cancer, diabetes, heart failure, chronic obstructive pulmonary disease etc. Amongst these, cancer is the main cause leading to cachexia. According to a study, it has been estimated that approximately 5 million Americans suffer from this condition. There are different conditions where a
Cancer Cachexia Market Research Report: Analysis & Trends 2024
Cancer cachexia is a complex metabolic condition which leads to progressive weight loss and depletion of host reserves of adipose tissue and skeletal muscle. Cachexia represents the clinical condition out of a chronic, systemic response that leads to rise in buildup of liver proteins and consequent depletion of essential amino acids. Cachexia causes additional problems as the patient becomes more prone to infections and less able to withstand the toxic